APA (7th ed.) Citation

Saleki, K., Shirzad, M., Javanian, M., Mohammadkhani, S., Alijani, M. H., Miri, N., . . . Azadmehr, A. (2022). Serum soluble Fas ligand is a severity and mortality prognostic marker for COVID-19 patients. Frontiers in immunology, 13, 947401. https://doi.org/10.3389/fimmu.2022.947401

Chicago Style (17th ed.) Citation

Saleki, Kiarash, Moein Shirzad, Mostafa Javanian, Sheyda Mohammadkhani, Mohammad Hossein Alijani, Niloufarsadat Miri, Morteza Oladnabi, and Abbas Azadmehr. "Serum Soluble Fas Ligand Is a Severity and Mortality Prognostic Marker for COVID-19 Patients." Frontiers in Immunology 13 (2022): 947401. https://doi.org/10.3389/fimmu.2022.947401.

MLA (9th ed.) Citation

Saleki, Kiarash, et al. "Serum Soluble Fas Ligand Is a Severity and Mortality Prognostic Marker for COVID-19 Patients." Frontiers in Immunology, vol. 13, 2022, p. 947401, https://doi.org/10.3389/fimmu.2022.947401.